TrialNature communications2024

Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913).

Maria Carmen Riesco-Martinez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.